2 points stood out for me on conversations with DT and PS in perth this week.
The first point was the absolutely critical importance of the upcoming trial design, Pete couldn't be more clear on how crucial this was and gave numerous examples of good drugs failing due to poor trial design, he also quipped that DT doesn't sleep in making sure this isn't the case for shareholders.
The second point was DT saying The Hoff and he speak on a daily basis and how genuinely excited DVH is with the upcoming trials, it's building and we have some incredible people at the wheel.
Ann: Distinguished Oncologist Daniel Von Hoff Joins as Consultant, page-139
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.59 |
Change
0.010(0.63%) |
Mkt cap ! $270.9M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.56 | $168.3K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 51 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.60 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |